Compare CBAN & NRC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | CBAN | NRC |
|---|---|---|
| Founded | 1975 | 1981 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Biotechnology: Commercial Physical & Biological Resarch |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 436.3M | 390.8M |
| IPO Year | 1995 | 1997 |
| Metric | CBAN | NRC |
|---|---|---|
| Price | $20.99 | $17.84 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 239.7K | 68.9K |
| Earning Date | 04-22-2026 | 05-05-2026 |
| Dividend Yield | 2.29% | ★ 3.76% |
| EPS Growth | 16.91 | ★ 4707.69 |
| EPS | 1.59 | ★ 50.00 |
| Revenue | N/A | ★ $119,686,000.00 |
| Revenue This Year | $35.41 | N/A |
| Revenue Next Year | $4.84 | N/A |
| P/E Ratio | $13.19 | ★ $0.34 |
| Revenue Growth | N/A | ★ 1.81 |
| 52 Week Low | $14.54 | $9.76 |
| 52 Week High | $21.46 | $22.79 |
| Indicator | CBAN | NRC |
|---|---|---|
| Relative Strength Index (RSI) | 68.91 | 61.27 |
| Support Level | $15.96 | $17.85 |
| Resistance Level | $21.04 | $18.18 |
| Average True Range (ATR) | 0.37 | 0.73 |
| MACD | 0.12 | -0.04 |
| Stochastic Oscillator | 85.04 | 95.10 |
Colony Bankcorp Inc is a bank holding company. The bank provides a broad range of banking services to its retail and commercial customers. Its product line includes loans to small and medium-sized businesses, residential and commercial construction and land development loans, commercial real estate loans, agri-business and production loans, residential mortgage loans, consumer loans, and a variety of demand, savings, and time deposit products. The company's segments include the Banking Division, Retail Mortgage Division and small business specialty lending divisions. It generates maximum revenue from the Banking Division.
National Research Corp is a provider of analytics and insights that facilitate measurement and improvement of the patient and employee experience while also increasing patient engagement and customer loyalty for healthcare providers, payers, and other healthcare organizations. Its portfolio of solutions represents a set of capabilities that individually and collectively provide value to clients. The company operates in the United States and Canada, of which key revenue is derived from the United States.